Healthcare Realty Trust Inc. - Q1 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2025. Healthcare Realty Trust Inc. (HR) is a real estate investment trust (REIT) focused on outpatient healthcare properties. As of the reporting date, the company owned or had interests in approximately 587 consolidated properties totaling roughly 34.3 million square feet across 33 states. The company operates as a single reportable segment.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Total Revenues | $298.98 million | $326.81 million |
| Net Loss (GAAP) | $(45.39) million | $(315.22) million |
| Net Loss Attributable to Common Stockholders | $(44.87) million | $(310.84) million |
| Diluted EPS | $(0.13) | $(0.82) |
| Funds From Operations (FFO) | $123.77 million | $(113.47) million |
| Normalized FFO | $137.72 million | $147.82 million |
| Funds Available for Distribution (FAD) | $102.22 million | $104.46 million |
| Cash Flow from Operating Activities | $47.79 million | $76.15 million |
| Total Debt (Notes and Bonds Payable) | $4.73 billion | $4.66 billion |
| Cash and Cash Equivalents | $25.72 million | $68.92 million |
Material Changes vs. Prior Period
- Revenue Decline: Total revenues decreased by $27.8 million (8.5%) year-over-year. Rental income dropped $29.2 million, primarily due to property dispositions in 2024 and 2025 ($38.7 million impact), partially offset by leasing activity ($7.7 million increase).
- Improved Net Loss: The net loss narrowed significantly from $315.2 million in Q1 2024 to $45.4 million in Q1 2025. The prior year loss was heavily impacted by a $250.5 million goodwill impairment charge, which did not recur in Q1 2025.
- Impairments: The company recognized $12.1 million in impairments of real estate properties and credit loss reserves in Q1 2025, compared to $15.9 million in Q1 2024. This included $5.4 million on properties sold and $4.8 million on properties with changed holding periods.
- Interest Expense: Interest expense decreased by $6.2 million (10.2%) to $54.8 million, driven by lower balances on unsecured term loans and the credit facility.
- Dispositions: The company sold four properties in Q1 2025 for a total sales price of $28.1 million, generating net proceeds of $16.3 million. This included a $5.4 million seller-financed note on a Houston property.
Outlook, Risks, and Management Commentary
- Liquidity: The company maintains $1.4 billion in availability on its unsecured credit facility. Management expects cash flows from operations to be sufficient to fund dividends for the full year 2025, though Q1 dividends were partially funded by the credit facility due to timing of interest payments.
- Dividends: A quarterly dividend of $0.31 per share was paid in Q1 2025. A subsequent dividend of $0.31 per share was declared on May 1, 2025.
- Key Risks:
- Tenant Bankruptcy: Prospect Medical Holdings filed for Chapter 11 bankruptcy in January 2025. The company leases ~81,000 sq. ft. to Prospect, representing ~$2.9 million in annual revenue. The company has moved these leases to cash-basis accounting and recorded a $0.7 million reserve in Q4 2024.
- Interest Rates: Rising rates increase the cost of capital and may impact tenant ability to pay rent. The company has $1.075 billion in interest rate swaps to hedge variable-rate debt.
- Lease Expirations: Approximately 15% of leases expire annually. 1,072 leases totaling 3.9 million sq. ft. are set to expire in the remainder of 2025.
- Capital Markets: In April 2025, the company extended the maturity of its $200 million term loan due May 2025 to January 2026. On May 1, 2025, the company repaid $250 million in Senior Notes due 2025 at maturity.
Investor Verification Checklist
- Prospect Medical Exposure: Verify the status of rent collections and potential further reserves related to the Prospect Medical bankruptcy.
- Debt Maturity Wall: Confirm the repayment schedule for the $250 million Senior Notes due 2025 (repaid May 1, 2025) and the extension terms of the $200 million term loan.
- FFO vs. GAAP Reconciliation: Review the significant adjustments (depreciation, impairments, transaction costs) that bridge the GAAP net loss to the positive FFO and Normalized FFO figures.
- Disposition Strategy: Assess the impact of ongoing property sales on future rental income streams and the reinvestment of proceeds.
- Interest Rate Hedging: Evaluate the effectiveness of the $1.075 billion in interest rate swaps against current market rates and future debt refinancing needs.